BRPI0412444B8 - fração de quil a com baixa toxidez e seu uso - Google Patents
fração de quil a com baixa toxidez e seu usoInfo
- Publication number
- BRPI0412444B8 BRPI0412444B8 BRPI0412444A BRPI0412444A BRPI0412444B8 BR PI0412444 B8 BRPI0412444 B8 BR PI0412444B8 BR PI0412444 A BRPI0412444 A BR PI0412444A BR PI0412444 A BRPI0412444 A BR PI0412444A BR PI0412444 B8 BRPI0412444 B8 BR PI0412444B8
- Authority
- BR
- Brazil
- Prior art keywords
- adjuvant
- fraction
- low toxicity
- lps
- derivatives
- Prior art date
Links
- 231100000053 low toxicity Toxicity 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 4
- 229930182490 saponin Natural products 0.000 abstract 4
- 150000007949 saponins Chemical class 0.000 abstract 4
- 235000017709 saponins Nutrition 0.000 abstract 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108010039939 Cell Wall Skeleton Proteins 0.000 abstract 1
- 108010028921 Lipopeptides Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004520 cell wall skeleton Anatomy 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 229940035032 monophosphoryl lipid a Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
"fração de quil a com baixa toxidez e seu uso". a invenção refere-se ao uso da fração a de quil a em conjunto com pelo menos um outro adjuvante para a preparação de uma composição adjuvante, em que os componentes adjuvantes incluídos atuam sinergicamente para aumentar o nível de resposta imune e apresentam atividade imuno-moduladora sinérgica sobre os antígenos ou imunógenos co-administrados. o pelo menos outro adjuvante pode ser escolhido de saponinas, de ocorrência natural, moléculas de saponina sintéticas ou semi-sintéticas, por exemplo, saponinas e frações de saponina de quil a, esqueleto de parede celular, polímeros em bloco, tdm, lipopeptídeos, lps e derivados de lps, lipídeo a de diferentes espécies de bactérias e derivados deste, por exemplo, monofosforil lipídeo a, variantes de cpg, ct e lt ou frações (derivados destes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0301998A SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Quil A fraction with low toxicity and use thereof |
| PCT/SE2004/001038 WO2005002620A1 (en) | 2003-07-07 | 2004-07-07 | Quil a fraction with low toxicity and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0412444A BRPI0412444A (pt) | 2006-09-19 |
| BRPI0412444B1 BRPI0412444B1 (pt) | 2016-06-14 |
| BRPI0412444B8 true BRPI0412444B8 (pt) | 2021-05-25 |
Family
ID=27731119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412444A BRPI0412444B8 (pt) | 2003-07-07 | 2004-07-07 | fração de quil a com baixa toxidez e seu uso |
Country Status (15)
| Country | Link |
|---|---|
| US (8) | US8821881B2 (pt) |
| EP (1) | EP1648505B1 (pt) |
| JP (1) | JP4731475B2 (pt) |
| AT (1) | ATE442164T1 (pt) |
| AU (1) | AU2004254152B2 (pt) |
| BR (1) | BRPI0412444B8 (pt) |
| CA (1) | CA2529363C (pt) |
| DE (1) | DE602004023089D1 (pt) |
| DK (1) | DK1648505T3 (pt) |
| ES (1) | ES2331952T3 (pt) |
| NZ (1) | NZ544299A (pt) |
| PL (1) | PL1648505T3 (pt) |
| SE (1) | SE0301998D0 (pt) |
| WO (1) | WO2005002620A1 (pt) |
| ZA (1) | ZA200600151B (pt) |
Families Citing this family (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE315405T1 (de) * | 1998-08-10 | 2006-02-15 | Antigenics Inc | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung |
| SE0202110D0 (sv) * | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| ES2433467T3 (es) | 2005-01-20 | 2013-12-11 | Isconova Ab | Composición de vacuna que comprende una proteína de unión a fibronectina o un péptido de unión a fibronectina |
| EP1764369A1 (de) * | 2005-09-16 | 2007-03-21 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants |
| WO2007110776A1 (en) | 2006-03-24 | 2007-10-04 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Storage of influenza vaccines without refrigeration |
| DK2054431T3 (da) | 2006-06-09 | 2012-01-02 | Novartis Ag | Konformere af bakterielle adhæsiner |
| WO2008031878A1 (en) * | 2006-09-15 | 2008-03-20 | Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH | A composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases |
| EP1902727A1 (de) * | 2006-09-22 | 2008-03-26 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants |
| CN101563090B (zh) * | 2006-11-20 | 2013-01-02 | 杜科姆公司 | 包含南美皂皮树皂苷的含脂质颗粒用于治疗癌症的用途 |
| PT2185191E (pt) | 2007-06-27 | 2012-11-27 | Novartis Ag | Vacinas contra a gripe com baixo teor de aditivos |
| GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
| ES2569907T3 (es) * | 2008-06-27 | 2016-05-13 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| CN102470168A (zh) * | 2009-07-10 | 2012-05-23 | 伊斯克诺瓦公司 | 新组合物 |
| CA2808556A1 (en) | 2010-09-20 | 2012-03-29 | Crucell Holland B.V. | Therapeutic vaccination against active tuberculosis |
| DK2750683T4 (da) | 2011-10-03 | 2021-04-12 | Croda Int Plc | Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærer for amfipatiske eller hydrofobe molekyler inden for medicin, herunder cancerbehandling, og i fødevarerelaterede forbindelser |
| IN2014CN04742A (pt) | 2011-11-28 | 2015-09-18 | Crucell Holland Bv | |
| US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
| KR102044051B1 (ko) | 2012-03-12 | 2019-11-12 | 얀센 백신스 앤드 프리벤션 비.브이. | 터미널 말단이 변경된 재조합 아데노바이러스의 배치 |
| US9125870B2 (en) | 2012-03-22 | 2015-09-08 | Crucell Holland B.V. | Vaccine against RSV |
| JP5845376B2 (ja) | 2012-03-22 | 2016-01-20 | クルセル ホランド ベー ヴェー | Ｒｓｖに対するワクチン |
| EP4272750A3 (en) | 2013-02-07 | 2024-01-24 | Children's Medical Center, Corp. | Protein antigens that provide protection against pneumococcal colonization and/or disease |
| BR112015021523A8 (pt) | 2013-03-08 | 2021-06-29 | Crucell Holland Bv | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis |
| WO2014163558A1 (en) | 2013-04-01 | 2014-10-09 | Moreinx Ab | Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds |
| PT2988780T (pt) | 2013-04-25 | 2019-03-25 | Janssen Vaccines & Prevention Bv | Polipeptídeos f de pré-fusão do rsv solúveis estabilizados |
| CN105452270B (zh) | 2013-05-30 | 2020-12-01 | 扬森疫苗与预防公司 | 流行性感冒病毒疫苗及其用途 |
| CN105408348B (zh) | 2013-06-17 | 2021-07-06 | 扬森疫苗与预防公司 | 稳定化的可溶性融合前rsv f多肽 |
| EP3017040B1 (en) | 2013-07-02 | 2018-06-06 | Janssen Vaccines & Prevention B.V. | Method for preparing virosomes |
| US10806779B2 (en) | 2013-07-02 | 2020-10-20 | Janssen Vaccines & Prevention B.V. | Method for preparing virosomes |
| KR20200039025A (ko) | 2013-09-19 | 2020-04-14 | 조에티스 서비시즈 엘엘씨 | 유성 아쥬반트 |
| DE102014005771A1 (de) | 2014-04-23 | 2015-10-29 | Clariant International Ltd. | Verwendung von wässrigen driftreduzierenden Zusammensetzungen |
| WO2016005480A1 (en) | 2014-07-10 | 2016-01-14 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
| EP3421046A1 (en) | 2014-11-04 | 2019-01-02 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv16 vaccines |
| MX391930B (es) | 2015-01-16 | 2025-03-21 | Zoetis Services Llc | Vacuna contra la fiebre aftosa. |
| AU2016249798B2 (en) | 2015-04-14 | 2022-05-26 | Janssen Vaccines And Prevention B.V. | Recombinant adenovirus expressing two transgenes with a bidirectional promoter |
| CN107847580B (zh) | 2015-07-07 | 2022-08-12 | 扬森疫苗与预防公司 | 针对rsv的疫苗 |
| AU2016289496B2 (en) | 2015-07-07 | 2021-02-04 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion RSV F polypeptides |
| HK1252967A1 (zh) | 2015-08-20 | 2019-06-06 | Janssen Vaccines & Prevention B.V. | 治疗性hpv18疫苗 |
| JP6975709B2 (ja) | 2015-09-02 | 2021-12-01 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | 安定化したウイルスクラスｉ融合タンパク質 |
| CN114617959A (zh) | 2015-09-03 | 2022-06-14 | 诺瓦瓦克斯股份有限公司 | 具有改进的稳定性和免疫原性的疫苗组合物 |
| RU2723039C2 (ru) | 2015-12-23 | 2020-06-08 | Пфайзер Инк. | Мутанты белка f rsv |
| MX2018012094A (es) | 2016-04-05 | 2019-01-10 | Janssen Vaccines & Prevention Bv | Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas. |
| AU2017248018A1 (en) | 2016-04-05 | 2018-09-27 | Janssen Vaccines & Prevention B.V. | Vaccine against RSV |
| EP3452087A1 (en) | 2016-05-02 | 2019-03-13 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv vaccine combinations |
| DE102016207877A1 (de) | 2016-05-09 | 2017-11-09 | Clariant International Ltd | Stabilisatoren für Silikatfarben |
| BR112018072865A2 (pt) | 2016-05-12 | 2019-04-30 | Janssen Vaccines & Prevention B.V. | promotor bidirecional potente e equilibrado |
| WO2017207477A1 (en) | 2016-05-30 | 2017-12-07 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion rsv f proteins |
| SG11201810078PA (en) | 2016-05-30 | 2018-12-28 | Janssen Vaccines & Prevention Bv | Stabilized pre-fusion rsv f proteins |
| US11001858B2 (en) | 2016-06-20 | 2021-05-11 | Janssen Vaccines & Prevention B.V. | Potent and balanced bidirectional promoter |
| US10744196B2 (en) | 2016-07-14 | 2020-08-18 | Janssen Vaccines & Prevention B.V. | HPV vaccines |
| JP6766260B2 (ja) | 2016-11-04 | 2020-10-07 | キャボット コーポレイションＣａｂｏｔ Ｃｏｒｐｏｒａｔｉｏｎ | 結晶性ポリエステル及び有機シリカを含有するナノコンポジット |
| JP6721797B2 (ja) | 2017-02-09 | 2020-07-15 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 異種遺伝子発現のための強力で短いプロモーター |
| CA3061278A1 (en) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
| CN111148509A (zh) | 2017-07-24 | 2020-05-12 | 诺瓦瓦克斯股份有限公司 | 治疗呼吸系统疾病的方法和组合物 |
| AU2018333566A1 (en) | 2017-09-15 | 2020-02-27 | Janssen Vaccines & Prevention B.V. | Method for the safe induction of immunity against RSV |
| PL3743106T3 (pl) | 2018-01-23 | 2022-11-14 | Janssen Vaccines & Prevention B.V. | Szczepionki przeciwko wirusowi grypy i ich zastosowanie |
| CN120227451A (zh) | 2018-03-19 | 2025-07-01 | 诺瓦瓦克斯股份有限公司 | 多价流感纳米颗粒疫苗 |
| GB201807303D0 (en) | 2018-05-03 | 2018-06-20 | London School Of Hygeine & Tropical Medicine | Glyconjugate vaccines |
| CA3098103A1 (en) | 2018-05-23 | 2019-11-28 | Adc Therapeutics Sa | Molecular adjuvant |
| PE20211469A1 (es) | 2018-11-13 | 2021-08-05 | Janssen Vaccines And Prevention B V | Proteinas f de prefusion del vrs estabilizadas |
| AU2020263900B2 (en) | 2019-04-25 | 2026-04-16 | Janssen Vaccines & Prevention B.V. | Recombinant influenza antigens |
| KR20220008875A (ko) | 2019-05-15 | 2022-01-21 | 얀센 백신스 앤드 프리벤션 비.브이. | 계절성 인플루엔자 백신과 아데노바이러스 기반 호흡기 세포융합 바이러스 백신의 공동투여 |
| US20220193219A1 (en) | 2019-05-15 | 2022-06-23 | Janssen Vaccines & Prevention B.V. | Prophylactic treatment of respiratory syncytial virus infection with an adenovirus based vaccine |
| JP7865873B2 (ja) | 2019-09-05 | 2026-05-26 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | インフルエンザウイルスワクチン及びその使用 |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| AU2021214064A1 (en) | 2020-01-27 | 2022-08-18 | Novavax, Inc. | Coronavirus vaccine formulations |
| TW202204380A (zh) | 2020-01-31 | 2022-02-01 | 美商詹森藥物公司 | 用於預防及治療冠狀病毒感染之組合物及方法－sars-cov-2疫苗 |
| KR20230009466A (ko) | 2020-05-11 | 2023-01-17 | 얀센 파마슈티칼즈, 인코포레이티드 | SARS-CoV-2 백신 |
| KR20230009445A (ko) | 2020-05-11 | 2023-01-17 | 얀센 파마슈티칼즈, 인코포레이티드 | 안정화된 코로나바이러스 스파이크 단백질 융합 단백질 |
| KR20230009489A (ko) | 2020-05-11 | 2023-01-17 | 얀센 파마슈티칼즈, 인코포레이티드 | 안정화된 코로나 바이러스 스파이크 단백질을 암호화하는 rna 레플리콘 |
| EP4171627A1 (en) | 2020-06-29 | 2023-05-03 | Janssen Vaccines & Prevention B.V. | Vaccine combination against respiratory syncytial virus infection |
| BR112022026974A2 (pt) | 2020-07-06 | 2023-01-24 | Janssen Pharmaceuticals Inc | Proteínas de fusão estabilizadas de proteínas de pico de coronavírus |
| JP7822149B2 (ja) | 2020-10-02 | 2026-03-02 | ファイザー・インク | Ｒｓｖ ｆタンパク質生産のための細胞培養工程 |
| WO2022175479A1 (en) | 2021-02-19 | 2022-08-25 | Janssen Vaccines & Prevention B.V. | Vaccine combinations against respiratory syncytial virus strain a and b infections |
| US20240228548A9 (en) | 2021-02-19 | 2024-07-11 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion rsv fb antigens |
| GB202102396D0 (en) | 2021-02-19 | 2021-04-07 | Adc Therapeutics Sa | Molecular adjuvant |
| AU2022249741A1 (en) | 2021-04-01 | 2023-09-21 | Msd International Business Gmbh | Stabilized pre-fusion piv3 f proteins |
| WO2023020939A1 (en) | 2021-08-17 | 2023-02-23 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
| WO2023047349A1 (en) | 2021-09-24 | 2023-03-30 | Janssen Pharmaceuticals, Inc. | Stabilized coronavirus spike protein fusion proteins |
| WO2023047348A1 (en) | 2021-09-24 | 2023-03-30 | Janssen Pharmaceuticals, Inc. | Stabilized corona virus spike protein fusion proteins |
| WO2023111725A1 (en) | 2021-12-14 | 2023-06-22 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
| EP4448802A1 (en) | 2021-12-16 | 2024-10-23 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
| JP2025511756A (ja) | 2022-04-08 | 2025-04-16 | フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー | ワクチン及び関連する方法 |
| AU2023269241A1 (en) | 2022-05-12 | 2024-11-21 | Msd International Business Gmbh | Stabilized pre-fusion hmpv fusion proteins |
| WO2024017682A1 (en) | 2022-07-18 | 2024-01-25 | Janssen Vaccines & Prevention B.V. | Rsv immunogens |
| US20240042021A1 (en) | 2022-08-01 | 2024-02-08 | Flagship Pioneering Innovations Vii, Llc | Immunomodulatory proteins and related methods |
| US20260085096A1 (en) | 2022-09-23 | 2026-03-26 | Janssen Vaccines & Prevention B.V. | Stabilized trimeric class i fusion proteins |
| WO2024061759A1 (en) | 2022-09-23 | 2024-03-28 | Janssen Vaccines & Prevention B.V. | Stabilized coronavirus s proteins |
| EP4590690A1 (en) | 2022-09-23 | 2025-07-30 | Janssen Vaccines & Prevention B.V. | Pre-fusion human piv1 f proteins |
| WO2024074584A1 (en) | 2022-10-06 | 2024-04-11 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion piv3 f proteins |
| US20260183380A1 (en) | 2022-11-14 | 2026-07-02 | Janssen Vaccines & Prevention B.V. | Influenza b virus vaccines and uses thereof |
| EP4648794A2 (en) | 2023-01-09 | 2025-11-19 | Flagship Pioneering Innovations VII, LLC | Vaccines and related methods |
| CN120548194A (zh) | 2023-01-18 | 2025-08-26 | 辉瑞公司 | 针对呼吸道疾病的疫苗 |
| TW202438515A (zh) | 2023-02-06 | 2024-10-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 免疫調節組合物及相關方法 |
| KR20250152090A (ko) | 2023-02-21 | 2025-10-22 | 엠에스디 인터내셔널 비즈니스 게엠베하 | 이종 삼량체화 도메인이 없는 안정화된 삼량체 rsv 융합 단백질 |
| WO2024258829A1 (en) | 2023-06-12 | 2024-12-19 | Flagship Pioneering Innovations Vii, Llc | Sars-cov-2 vaccine compositions and related methods |
| US20250375499A1 (en) | 2024-01-26 | 2025-12-11 | Flagship Pioneering Innovations Vii, Llc | Immunoreceptor inhibitory proteins and related methods |
| WO2025163460A2 (en) | 2024-01-30 | 2025-08-07 | Pfizer Inc. | Vaccines against respiratory diseases |
| TW202613158A (zh) | 2024-05-16 | 2026-04-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 免疫受體抑制蛋白及相關方法 |
| WO2025245111A1 (en) | 2024-05-22 | 2025-11-27 | Flagship Pioneering Innovations Vii, Llc | Immunoreceptor targeting proteins and related methods |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| WO2026038177A1 (en) | 2024-08-16 | 2026-02-19 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| WO2026122747A2 (en) | 2024-12-05 | 2026-06-11 | Flagship Pioneering Innovations Vii, Llc | Novel immunomodulatory proteins and related methods |
| US20260166136A1 (en) | 2024-12-18 | 2026-06-18 | Pfizer Inc. | Immunogenic compositions and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5839376B2 (ja) * | 1978-10-30 | 1983-08-30 | 富士通株式会社 | イオン注入法 |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| ES2039229T3 (es) | 1986-01-14 | 1993-09-16 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos. |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| NL9002314A (nl) | 1990-10-23 | 1992-05-18 | Nederlanden Staat | Immunogene complexen, in het bijzonder iscoms. |
| AUPM873294A0 (en) * | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| SE9600647D0 (sv) * | 1996-02-21 | 1996-02-21 | Bror Morein | Ny användning |
| US6231859B1 (en) | 1996-12-02 | 2001-05-15 | Aquila Biopharmaceuticals, Inc. | Saponin adjuvant compositions |
| AUPO517897A0 (en) | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
| US6558670B1 (en) * | 1999-04-19 | 2003-05-06 | Smithkline Beechman Biologicals S.A. | Vaccine adjuvants |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
-
2003
- 2003-07-07 SE SE0301998A patent/SE0301998D0/xx unknown
-
2004
- 2004-07-07 BR BRPI0412444A patent/BRPI0412444B8/pt active IP Right Grant
- 2004-07-07 ES ES04749076T patent/ES2331952T3/es not_active Expired - Lifetime
- 2004-07-07 CA CA2529363A patent/CA2529363C/en not_active Expired - Lifetime
- 2004-07-07 PL PL04749076T patent/PL1648505T3/pl unknown
- 2004-07-07 NZ NZ544299A patent/NZ544299A/en not_active IP Right Cessation
- 2004-07-07 DE DE602004023089T patent/DE602004023089D1/de not_active Expired - Lifetime
- 2004-07-07 WO PCT/SE2004/001038 patent/WO2005002620A1/en not_active Ceased
- 2004-07-07 DK DK04749076T patent/DK1648505T3/da active
- 2004-07-07 JP JP2006518582A patent/JP4731475B2/ja not_active Expired - Lifetime
- 2004-07-07 AT AT04749076T patent/ATE442164T1/de not_active IP Right Cessation
- 2004-07-07 US US10/562,866 patent/US8821881B2/en not_active Expired - Lifetime
- 2004-07-07 AU AU2004254152A patent/AU2004254152B2/en not_active Expired
- 2004-07-07 EP EP04749076A patent/EP1648505B1/en not_active Expired - Lifetime
-
2006
- 2006-01-06 ZA ZA200600151A patent/ZA200600151B/en unknown
-
2014
- 2014-07-29 US US14/445,690 patent/US20140335049A1/en not_active Abandoned
-
2015
- 2015-05-18 US US14/714,664 patent/US20150320858A1/en not_active Abandoned
-
2016
- 2016-02-26 US US15/054,801 patent/US20160184427A1/en not_active Abandoned
-
2018
- 2018-01-18 US US15/874,262 patent/US20180369368A1/en not_active Abandoned
-
2019
- 2019-12-03 US US16/701,948 patent/US20200345840A1/en not_active Abandoned
-
2021
- 2021-09-17 US US17/477,739 patent/US20220241408A1/en not_active Abandoned
-
2023
- 2023-10-04 US US18/376,666 patent/US12171828B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0412444A (pt) | 2006-09-19 |
| JP2007527386A (ja) | 2007-09-27 |
| US20150320858A1 (en) | 2015-11-12 |
| ZA200600151B (en) | 2007-01-31 |
| AU2004254152A1 (en) | 2005-01-13 |
| DK1648505T3 (da) | 2009-12-21 |
| BRPI0412444B1 (pt) | 2016-06-14 |
| EP1648505B1 (en) | 2009-09-09 |
| SE0301998D0 (sv) | 2003-07-07 |
| US20140335049A1 (en) | 2014-11-13 |
| US20180369368A1 (en) | 2018-12-27 |
| US20240024468A1 (en) | 2024-01-25 |
| US20060239963A1 (en) | 2006-10-26 |
| ES2331952T3 (es) | 2010-01-21 |
| US12171828B2 (en) | 2024-12-24 |
| US8821881B2 (en) | 2014-09-02 |
| EP1648505A1 (en) | 2006-04-26 |
| PL1648505T3 (pl) | 2010-02-26 |
| US20220241408A1 (en) | 2022-08-04 |
| JP4731475B2 (ja) | 2011-07-27 |
| US20160184427A1 (en) | 2016-06-30 |
| US20200345840A1 (en) | 2020-11-05 |
| NZ544299A (en) | 2009-03-31 |
| WO2005002620A1 (en) | 2005-01-13 |
| CA2529363C (en) | 2013-04-02 |
| DE602004023089D1 (de) | 2009-10-22 |
| AU2004254152B2 (en) | 2009-10-29 |
| ATE442164T1 (de) | 2009-09-15 |
| CA2529363A1 (en) | 2005-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0412444A (pt) | fração de quil a com baixa toxidez e seu uso | |
| BRPI0619795B8 (pt) | composição imunogênica, composição adjuvante, e, uso de uma composição imunogênica e um adjuvante | |
| Barr et al. | ISCOMs and other saponin based adjuvants | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| BR0209689A (pt) | Uso de fragmento de hmg como agente anti-inflamatório | |
| PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
| UY27843A1 (es) | Composicion de vacuna | |
| ATE116993T1 (de) | Saponin-hilfsmittel. | |
| CR8862A (es) | Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune | |
| BRPI0717183B8 (pt) | exendina ou análogo de exendina modificada por peg, composição e seu uso | |
| BRPI0510394A (pt) | inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 | |
| BRPI0914536A8 (pt) | Tiadiazoliloxifenilamidinas, processo para sua preparação e seus usos, composição e processo para combater microorganismos indesejáveis, e semente resistente a microorganismos indesejáveis | |
| BRPI0309421B8 (pt) | método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia | |
| CL2009000757A1 (es) | Compuestos derivados de 6,8,2´-tris-(isobut-2-en-1-il)-diosmetina; procedimientos para su elaboracion; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades venosas cronicas, sindrome post-trombotico, complicaciones vasculares ligadas a la diabetes, entre otras. | |
| BR0312472A (pt) | Prepração de uma composição compreendendo uma mistura de complexos de iscom e uso da dita composição | |
| BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
| ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
| PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| ES2140837T3 (es) | Adyuvante a base de saponina de madera de panama y formulacion de vacuna que lo contiene. | |
| BRPI0820258B8 (pt) | composto, composições de vacina, e, uso de um composto | |
| BR112012006872A2 (pt) | composição, promotor de lipólise oral, inibidor de enzima de conversão de angiotensina oral, e, alimento ou bebida | |
| BRPI0510396A (pt) | vacina compreendendo um pestivìrus atenuado | |
| BRPI0513288A (pt) | uso de alcanóis fosfatados como dispersantes, emulsificantes, hodrótropos, agentes umectantes e agentes de compatabilidade em composições agriculturais | |
| KR960703611A (ko) | 산사나무속 종, 약제 조성물의 제조 및 심장정지와 재환류 유발 심장혈관 병변에 의한 급사방지를 위한 그의 사용 | |
| BRPI0507111A (pt) | processo para a preparação de um composto e seus adutos de mannich, composição, concentrado aditivo para combustìveis, e, usos de uma composição e de pelo menos um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/06/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |